Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Lam

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Elife|August 1, 2015
Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Jia Li, Matthew Lam,
Children (Basel, Switzerland)|December 23, 2022
Screening, Diagnosis, and Treatment of Pediatric Ocular DiseasesMatthew Lam, Donny Suh
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|August 7, 2020
Factors affecting performance and manufacturability of naproxen Liqui-PelletMatthew Lam, Ali Nokhodchi
Pharmaceutics|August 10, 2021
Liqui-Mass Technology as a Novel Tool to Produce Sustained Release Liqui-Tablet Made from Liqui-PelletsMatthew Lam, Nour Nashed, Ali Nokhodchi
ANZ Journal of Surgery|May 18, 2020
Subglottic plasma cell mucositis: a case study highlighting challenge in managementHolly Kristensen, Matthew Lam, Stuart MacKay
AAPS Pharmscitech|June 26, 2019
Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization TechnologyMatthew Lam, Taravat Ghafourian, Ali Nokhodchi
AAPS Pharmscitech|March 18, 2020
Liquisolid System and Liqui-Mass System Are Not the SameMatthew Lam, Taravat Ghafourian, Ali Nokhodchi
Journal of Investigative Medicine High Impact Case Reports|July 31, 2025
Streptococcal Pharyngitis Complicated by Clinically Significant Rheumatic Myopericarditis: A Case ReportAmanda Nguyen, Garrett Cohen, Matthew Lam
International Journal of Pharmaceutics|January 23, 2021
A comprehensive overview of extended release oral dosage forms manufactured through hot melt extrusion and its combination with 3D printingNour Nashed, Matthew Lam, Ali Nokhodchi
Drug Delivery and Translational Research|July 10, 2019
Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage formMatthew Lam, Taravat Ghafourian, Ali Nokhodchi
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Elife|August 1, 2015
Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44Jia Li, Matthew Lam,
Children (Basel, Switzerland)|December 23, 2022
Screening, Diagnosis, and Treatment of Pediatric Ocular DiseasesMatthew Lam, Donny Suh
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|August 7, 2020
Factors affecting performance and manufacturability of naproxen Liqui-PelletMatthew Lam, Ali Nokhodchi
Pharmaceutics|August 10, 2021
Liqui-Mass Technology as a Novel Tool to Produce Sustained Release Liqui-Tablet Made from Liqui-PelletsMatthew Lam, Nour Nashed, Ali Nokhodchi
ANZ Journal of Surgery|May 18, 2020
Subglottic plasma cell mucositis: a case study highlighting challenge in managementHolly Kristensen, Matthew Lam, Stuart MacKay
AAPS Pharmscitech|June 26, 2019
Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization TechnologyMatthew Lam, Taravat Ghafourian, Ali Nokhodchi
AAPS Pharmscitech|March 18, 2020
Liquisolid System and Liqui-Mass System Are Not the SameMatthew Lam, Taravat Ghafourian, Ali Nokhodchi
Journal of Investigative Medicine High Impact Case Reports|July 31, 2025
Streptococcal Pharyngitis Complicated by Clinically Significant Rheumatic Myopericarditis: A Case ReportAmanda Nguyen, Garrett Cohen, Matthew Lam
International Journal of Pharmaceutics|January 23, 2021
A comprehensive overview of extended release oral dosage forms manufactured through hot melt extrusion and its combination with 3D printingNour Nashed, Matthew Lam, Ali Nokhodchi
Drug Delivery and Translational Research|July 10, 2019
Optimising the release rate of naproxen liqui-pellet: a new technology for emerging novel oral dosage formMatthew Lam, Taravat Ghafourian, Ali Nokhodchi
Pageof 5